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ABSTRACT 
Streptococcus dysgalactiae spp. dysgalactiae is an important causative agent of bovine 
mastitis worldwide. Lactoferrin is an innate immune protein that is associated with many 
functions including immunomodulatory, antiproliferative and antimicrobial properties. This 
study aimed to investigate the interactions between lactoferrin and a clinical bovine mastitis 
isolate, S. dysgalactiae spp. dysgalactiae DPC5345.  Initially a deliberate in vivo bovine 
intramammary challenge was performed with S. dysgalactiae DPC5345. Results 
demonstrated a significant difference in lactoferrin mRNA levels in milk cells between the 
control and infused quarters 7 hours post infusion. Milk lactoferrin levels in the S. 
dysgalactiae DPC5345 infused quarters were significantly increased compared to control 
quarters at 48 h post infusion. In vitro studies demonstrated that lactoferrin had a 
bacteriostatic effect on the growth of S. dysgalactiae DPC5345 and significantly decreased 
the ability of the bacteria to internalise into HC-11 mammary epithelial cells.  Confocal 
microscopy images of HC-11 cells exposed to S. dysgalactiae and lactoferrin further 
supported this effect by demonstrating reduced invasion of bacteria to HC-11 cells. The 
combined data suggests that a bovine immune response to S. dysgalactiae infection includes a 
significant increase in lactoferrin expression in vivo and, based on in vitro data, lactoferrin 
limits mammary cell invasion of this pathogen by binding to the bacteria and preventing its 
adherence. 
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INTRODUCTION 
Bovine mastitis infection has serious deleterious effects on milk quality and is a 
significant limiting factor to profitable dairy farming worldwide (Bar et al., 2008; Berry and 
Amber, 2005; Kossaibati and Esslemon, 1997). Mastitis infection occurs when a bacterial 
pathogen gains entry to the mammary gland via the teat canal. Infection is then established 
through bacterial evasion of both the anatomical and humoral defence mechanisms of the 
mammary gland (Zhao and Lacasse, 2008) 
Streptococcus dysgalactiae subspecies dysgalactiae (S. dysgalactiae) has been described 
as both a contagious mastitis pathogen (Fox et al., 1993) and an environmental pathogen 
(Calvinho et al., 1998) and has been detected in clinical and subclinical bovine mastitis cases 
(Girma et al., 2012; Bitew et al., 2010; Piepers et al., 2007; Barrett et al., 2005). Traditional 
mastitis control programmes have had limited effects on reducing the incidence of S. 
dysgalactiae infections due to the adaptability of the bacteria (Bolton et al., 2004). S. 
dysgalactiae have cell-associated and extracellular virulence factors which contribute to the 
establishment and persistence of intramammary infection (IMI). In vitro studies have 
demonstrated that the bacteria can adhere to mammary epithelial cells and internalise 
(Calvinho and Oliver, 1998a; Almeida and Oliver, 1995). Once internalised within the cell, 
the bacteria can survive by evading the action of antimicrobial drugs and host immune 
defence components. 
Conventional treatment for mastitis involves the administration of antibiotics. 
Antimicrobial resistance in mastitis pathogens is not yet considered a clinically relevant issue 
(Oliver and Murinda, 2012; Pyorala, 2009), however, the intensive use of antibiotics can lead 
to the development of resistant strains (Hendriksen, 2008). In addition, dairy cows produce 
milk for human consumption, therefore, antibiotic traces in milk is a public health concern. 
The development of effective, alternative approaches to control and/or treat mastitis would be 
4 
 
of significant benefit to the dairy industry. One approach would be to manipulate and 
enhance natural host defence mechanisms. However, different pathogens display distinct 
invasion and pathogenic mechanisms (Chaneton et al., 2008). Detailed knowledge of the 
specific host-pathogen interactions that are required to establish and develop IMI is 
fundamental to the design of adequate treatment and control policies. 
Lactoferrin is an innate immune protein that is predominantly secreted in vivo by 
neutrophils and specific glandular tissue (Ling and Schryvers, 2006). Its production is both 
constitutively and differentially regulated in a tissue-specific manner (Teng et al., 2002).  
Lactoferrin is a multifunctional protein being associated with antibacterial, 
immunomodulatory, antiadhesive and iron-binding properties (Chierici, 2001; Ueta et al., 
2001; Ajello et al., 2002). It is described as broad spectrum, affecting the growth and 
proliferation of a variety of gram negative and gram positive pathogens (Adlerova et al., 
2008) with both bacteriostatic and bacteriocidal effects (Kutila et al., 2003). Bovine milk 
lactoferrin levels change over the course of lactation, as well as in response to mammary 
gland infections (Kawai et al., 1999). Bahar et al (2011) also demonstrated that genetic 
polymorphisms within the lactoferrin gene promoter can affect milk lactoferrin levels.  
In general, streptococcal species are considered more resistant to the antibacterial effects 
of lactoferrin (Fang et al., 2000). This may be due to the fact that streptococcal species have 
low iron requirements (Weinberg, 1978) or it may be due to their ability to extract the metal 
from iron-containing host proteins (Ruiguang et al., 2009). Indeed lactoferrin binding 
proteins have been found in several streptococcal species, including S. uberis, S. agalactiae 
and S. dysgalactiae (Park et al., 2002a), suggesting a role for lactoferrin in relation to 
streptococcal infections, which may have important implications for the pathogenesis of IMI. 
Patel et al (2009) demonstrated that S. uberis isolates bind lactoferrin via a surface-exposed 
adhesion molecule which they defined as the S. uberis adhesion molecule (SUAM). These in 
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vitro studies suggest that S. uberis hijacks lactoferrin to act as a bridging molecule between 
the bacterial cell surface and lactoferrin receptors on host mammary epithelial cells. This 
allows S. uberis to adhere, invade and establish within bovine mammary epithelial cells. 
Interestingly in vivo bovine studies by Chaneton et al (2008) demonstrated that in subclinical 
cases of mastitis, bovine milk lactoferrin levels significantly increased in S. uberis infected 
quarters (P<0.001) when compared to uninfected quarters. It was hypothesized that S. uberis 
isolates were resistant to bovine lactoferrin activity and high levels of the lactoferrin in milk 
promoted the pathogenesis of S. uberis in vivo. Other mastitis-causing bacteria, including S. 
aureus, S. dysgalactiae and coagulase negative staphylococcus were not associated with a 
significant increase in bovine milk lactoferrin levels in these subclinical cases. (Almeida et 
al., 2006). These studies suggest that lactoferrin secretion in the bovine mammary gland is a 
pathogen-specific response. 
Park et al (2002b), using SDS-PAGE and western blotting, confirmed the expression of 
two lactoferrin binding proteins in S. dysgalactiae isolates (52- and 74KDa) and three 
lactoferrin binding proteins in S. agalactiae isolates (52-,70- and 110 KDa).  However, 
studies on the specific interaction between these streptococcal species and lactoferrin is 
limited and thus the role of lactoferrin binding proteins in the pathogenesis of S. dysgalactiae 
and S. agalactiae intramammary infections must still be elucidated.  
The aim of this study was to investigate the interaction in vitro between lactoferrin and S. 
dysgalactiae in order to identify whether this milk protein combats or promotes S. 
dysgalactiae infection. In vivo studies were conducted to quantify the changes in milk 
lactoferrin levels over the course of a mammary gland infection caused by a deliberate 
challenge with S. dysgalactiae  
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MATERIALS AND METHODS 
Bacterial Culture 
Streptococcus. dysgalactiae subspecies dysgalactiae (S. dysgalactiae) DPC 5345 was isolated 
on a Teagasc farm from a clinical mastitis case. The isolate was confirmed as streptococcus 
by selective plating on blood-esculin agar plates and characterised to species level by 16s 
PCR (Riffon et al, 2001). A 2 % inoculum of S. dysgalactiae DPC 5345 yielded 108 colony 
forming units (CFU) /ml when cultured overnight at 37 oC in tryptic soy (TS) broth (Difco 
Laboratories, Detroit, USA). 
 
Animal selection 
Five Holstein-Friesian cows were selected, based on their health status, for a deliberate 
intramammary challenge with S. dysgalactiae DPC 5345. These were spring-calving cows 
that were based on Teagasc research stations in the south of Ireland. Health status was 
determined using visual examination of milk and udders and milk somatic cell counts (SCC), 
with a count of <200,000 cells/ml considered as healthy. In addition, no pathogens were 
isolated from the quarter milks of test animals for 7 consecutive days prior to the challenge. 
Bacterial infusions and milk and blood sampling were performed under licence from the Irish 
Department of Agriculture and Food and approved by the Teagasc ethical committee. 
Following infusions, the health of the animals was monitored by trained farm staff and 
veterinary personnel.  For animal welfare purposes, intramammary-challenged cows received 
antibiotic treatment (Leo Yellow; Boehringer Ingelheim, Berkshire, UK) as soon as clinical 
signs of infection were observed.  
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Intramammary challenge 
The intramammary challenge with S. dysgalactiae DPC5345 was performed according to a 
procedure described by Beecher et al. (2012). Briefly, overnight cultures of S. dysgalactiae 
DPC5345 were diluted with maximum recovery diluent (MRD; Oxoid Ireland, Dublin, 
Ireland) to prepare 2 ml suspensions at 2500 CFU dysgalactiae.  This bacterial count was 
chosen as preliminary trials indicated that 2500 CFU is sufficient to cause infection (Beecher 
et al., 2012). Immediately after morning milking, one quarter from each animal was infused 
with the bacterial suspension into the teat sinus via the streak canal. The contra-lateral quarter 
was infused with 2 ml of MRD only and served as the internal control. Total quarter milk 
samples (or up to 2 L volume) were collected from each infused and control quarter 
immediately prior to infusion and at 7 h, 24 h, 48 h, 7 days and 14 days post infusion. From 
each milk sample 100 L was plated onto esculin blood agar plates (Thermo Scientific, 
Wilmington, DE, USA) to monitor bacterial infection. Milk somatic cell counts were also 
determined using a Somacount 300 somatic cell counter (Bently instruments Inc., Chaska, 
MN, USA). For animal welfare purposes, intramammary-challenged cows received antibiotic 
treatment (Leo Yellow; Boehringer Ingelheim, Berkshire, UK) as soon as clinical signs of 
infection were observed.  
 
RNA extraction from somatic cells 
To isolate RNA from milk somatic cells, 1 ml 0.5 M EDTA (Sigma-Aldrich, Ireland) was 
added to each litre of milk and the samples were then centrifuged at 1500 x g for 30 min at  
4 C. The fat layer was removed and cell pellets were washed twice with PBS (pH 7.4) 
containing 0.5 mM EDTA. Pellets were then re-suspended in 1 ml TriPure isolation reagent 
(Roche Diagnostics, East Sussex, UK) and RNA was extracted according to the 
manufacturers’ instructions. All RNA was quality assessed through visualisation on glyoxyl 
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gels (1.5 %) (Ambion, Applied Biosystems, Foster City, USA) and quantified using the 
Nanodrop 1000 (Thermo Scientific, Wilmington, DE, USA).  
 
 
Real-time PCR 
One microgram of RNA was converted to cDNA using the QuantiTect® Reverse 
Transcription Kit (Qiagen, Crawley, West Sussex, UK), and 1 μl cDNA was used per 
subsequent real-time PCR reaction. Primers designed by Li et al. (2009) were used to detect 
and amplify the lactoferrin gene (forward primer 5'-AAACAAGCATCGGGATTCCAG-3' 
and reverse primer 5'-ACAATGCAGTCTTCCGTGGTG-3'). Quantitative analysis was 
performed in a LightCycler 480 instrument (Roche Diagnostics, East Sussex, UK) using a 
dilution series of external plasmid DNA standards (109 - 102 copies/µl) (Pfaffl, 2001). 
Plasmid standards were created by cloning a cDNA PCR product into plasmid pCR TOPO 
(Invitrogen, Life Technologies, California,USA). Cloning was confirmed by sequencing 
(Beckman Coulter Genomics, Essex, UK). One microlitre of each dilution was used per 10 l 
LightCycler reaction. The LightCycler 480 SYBR Green I Master kit (Roche Diagnostics, 
East Sussex, UK) was used for quantification according to the manufacturer’s instructions 
using 0.5 M of each of the forward and reverse primers. The assay began with initial 
denaturation at 95C for 10 min, followed by 40 cycles of quantification with 5 s 
denaturation at 95 C, 10 s annealing at 60 oC and 25 s elongation at 72 C. Melting curve 
analysis was performed by heating, from a temperature 5 C above the annealing 
temperature, to 95 C in the continuous fluorescence acquisition mode to ensure specificity of 
LightCycler product. LightCycler runs were performed in triplicate incorporating negative 
controls (no DNA template) in each run and according to MIQE guidelines (Bustin et al., 
2009).  
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Protein quantitation by ELISA 
Milk lactoferrin was quantitated using an ELISA kit (Bethyl Laboratories Inc., Montgomery 
Texas, USA) and according to the manufacturers’ instructions. Milk samples were diluted 
1:2000 and standard curves generated for each sample set. Minimum detection levels for 
lactoferrin were 7.8 ng/ml lactoferrin concentrations were quantified by interpolating the 
absorbance values from the standard curve. Test samples were analysed by ELISA in 
duplicate and the analysis performed on 2 separate occasions.  
 
Antibacterial assay 
The antibacterial activity of a commercial bovine native lactoferrin protein (#L9507, Sigma-
Aldrich, Ireland) was tested against S. dysgalactiae DPC5345. For this, an overnight culture 
of S. dysgalactiae DPC 5345 was diluted to 107 CFU/ml in TS broth (Oxoid, Ireland) and 40 
μl of the culture added to each test well in a 96 well plate. The lactoferrin protein was initially 
prepared at a stock of 20 mg/ml by diluting in distilled water and sterile filtered using 0.45 
m filters (Millipore, UK). The final concentrations of lactoferrin tested were 0.02, 0.2, 2.0, 
5.0 and 10.0 mg/ml. Plates were incubated at 37 C and growth curves generated by 
measuring absorbance at 620 nm every hour for 24 h using a spectrophotometer. Assays were 
performed in triplicate. 
 
Cell line and tissue culture  
The HC-11 murine mammary epithelial cell line used in this study was kindly donated by Dr. 
Wolfgang Doppler (Innsbruck Medical University, Austria). Cells were grown and 
maintained in RPMI 1640 media (Sigma-Aldrich, Ireland) supplemented with 4 mM L-
Glutamine (Sigma-Aldrich), 10 % foetal bovine serum (FBS; Sigma-Aldrich, Ireland),  
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5 μg/ml insulin (Sigma-Aldrich), 10 ng/ml epidermal growth factor (EGF, Sigma-Aldrich, 
Ireland), 100 U/ml penicillin (Sigma-Aldrich, Ireland) and 100 μg/ml streptomycin (Sigma-
Aldrich, Ireland).  
 
 
Invasion assays with S. dysgalactiae 
Invasion assays were performed on the same day, in triplicate, as per Calvinho and Oliver 
(1998b) with some minor modifications. Briefly, HC-11 cells were seeded into 24-well plates 
at a density of 1 x 105 cells/well and grown to confluency in antibiotic-free RMPI 1640 
supplemented media. An overnight culture of S. dysgalactiae DPC 5345 was washed 3 times 
in phosphate buffered saline (PBS; Sigma-Aldrich, Ireland) and re-suspended in antibiotic-
free RPMI 1640 supplemented media, to a final concentration of ~1 x 107 CFU/ml. On the 
day of the assay, HC-11 cell monolayers were washed 3 times in PBS and 1 ml aliquots of 
the bacterial culture (1 x 107 CFU/ml) was added to each test well. Sterile-filtered solutions 
of lactoferrin, prepared with antibiotic-free RPMI 1640 supplemented media, were added (1 
ml) to test wells such that the final concentrations tested were 0.01, 0.1, 1.0 and 2.0 mg/ml 
lactoferrin. Control wells contained S. dysgalactiae DPC5345 culture and 1 ml PBS only. 
Plates were incubated at 37C, 5% CO2 for 2 h. Supernatants were aspirated off into sterile 
1.5 ml eppendorf tubes and diluted 10-fold for bacterial counting. Culture wells were then 
washed 3 times with PBS (1 ml), followed by incubation for a further 2 h in RPMI 1640 
supplemented media containing 5 ug/ml penicillin and 100 U/ml gentamicin. Following the 
second incubation, media was removed and cells were washed 3 times with 1 ml PBS. HC-11 
cells were then lysed by adding 0.25 % trypsin (Sigma-Aldrich, Ireland) and 0.025 % Triton 
X-100 (Sigma-Aldrich, Ireland) and the lysates collected into sterile 1.5 ml eppendorfs and 
vigorously vortexed for 15 seconds. Cell lysates were serially diluted 10-fold (10-1 to 10-4) 
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and 0.1 ml dilutions plated onto TS agar plates for bacterial counting and incubated at 37C 
overnight. Adherence, at lactoferrin concentrations tested, was expressed as (CFU/ml in the 
cell lysates) / (CFU/ml in the supernatant) X 10,000 (Fang et al., 2000). Each lactoferrin 
concentration was tested in duplicate and the assays performed on four separate occasions. 
 
Confocal Scanning Microscopy and Live/Dead staining 
For confocal microscopy experiments, HC-11 cells were seeded onto 10 cm diameter tissue 
culture dishes (Sarstedt, Drinagh, Wexford, Ireland), at a concentration of 1 x 106 cells/well, 
and grown to confluency. A fresh overnight bacterial culture of S. dysgalactiae DPC5345 
was washed 3 times with PBS and prepared in antibiotic-free RPMI 1640 supplemented 
media to a final concentration of ~1 x 107 CFU/ml. A 2 mg/ml protein preparation of 
commercially available bovine Lactoferrin was prepared in PBS and labelled with a Dylight 
633 Fluorescent dye using an Alexa Fluor 350 Protein labelling kit (Thermo Fisher Scientific, 
Dublin, Ireland), according to the manufacturers’ instructions. One ml of the labelled protein 
solution was mixed with 1 ml of fresh bacterial culture (~107 CFU/ml) and added to cell 
culture dishes containing confluent HC-11 monolayer of cells. Controls included HC-11 
monolayers exposed to (a) 2 ml antibiotic-free RPMI 1640 supplemented media only and (b) 
1 ml antibiotic-free RPMI 1640 supplemented media mixed with 1 ml bacterial culture (~107 
CFU/ml). All cell culture plates were incubated for 2 h at 37 C, 5 % CO2 and then the media 
removed before washing twice with PBS (5 ml). 
Before imaging, cells were stained with the Live/Dead BacLight Bacterial Viability 
Kit solution (Molecular Probes, Inc., Eugene, OR, USA). An argon ion laser was used to 
generate the 488 line used for excitation. Imaging was performed using a Leica TCS SP5 
confocal laser scanning microscope (Leica Microsystems, Heildelberg GmbH, Mannheim, 
Germany) using a 63 x oil immersion objective (AN = 1.4). RGB colour images (24 bit), 512 
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x 512 pixels in size, were acquired. A minimum of 4 z-stacks were taken per sample with 
representative cross sections of micrographs shown. 
 
 
Statistical Analysis 
For statistical analysis, gene expression data was transformed by obtaining the natural 
logarithm. A hierarchical mixed model (PROC MIXED; SAS Version 9.1, SAS Institute Inc., 
Cary, NC, USA) was used to quantify the effect of treatment (control or infused) on gene 
expression and the dependent variable was transformed gene expression.. Fixed effects 
included in the model were time relative to the start of the study, treatment and time by 
treatment interaction. Where significant (P < 0.05), a covariate, which was the gene 
expression for the control and infused quarters at time zero, was included as a fixed effect. 
Time relative to the start of experiment was included as a repeated effect within the udder 
quarter, and cow was included as a random effect. Least squares means were extracted from 
the analysis and differences between the control and infused quarters were considered 
significant at P < 0.05. With regards to the milk protein secretion data statistical analysis was 
performed as above, without transformation, as data was normally distributed. As with gene 
expression data differences between the control and infused quarters were considered 
significant at P < 0.05. 
For the antibacterial assay, a paired Student’s T-test was employed to investigate the 
effect of different lactoferrin concentrations on bacterial growth. The bacteriostatic effect of 
each concentration tested was considered significantly different from the control at P < 0.05.  
A paired Student’s T-test was also employed in the invasion assay to identify 
differences in bacterial counts recovered. The number of bacteria recovered from different 
experiments were considered significantly different at P < 0.05.  
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RESULTS 
The effect of a deliberate intramammary challenge with S. dysgalactiae on lactoferrin levels 
in vivo was investigated to determine if the bovine immune response to this mastitis pathogen 
included alterations to the transcription and/or secretion of this antibacterial protein.   
 
Bacterial growth in infected quarters post intramammary challenge 
Following the infusion of experimental quarters with 2500 CFU S. dysgalactiae DPC5345 
viable gram-positive bacteria were recovered within 24 h from all quarters infused. Pulsed-
field gel electrophoresis (PFGE) confirmed S. dysgalactiae DPC5345 (data not shown). As 
soon as clinical signs of infection were observed (rectal temperartures > 38.5 ◦C, swollen 
udders and SCC > 200,000) animals received antibiotic (Leo Yellow) treatment. Four of the 
animals received antibiotic treatment 48 h post infusion and one animal received antibiotics 
at 72 h post infusion. Data post antibiotic treatment was discounted and not included in the 
analysis. 
.  
In vivo levels of lactoferrin mRNA and protein following intramammary challenge 
To investigate if lactoferrin gene expression and / or lactoferrin protein levels in milk were 
affected by the deliberate S. dysgalactiae DPC5345 intramammary challenge lactoferrin 
mRNA and protein levels were measured in the control quarters and the infused quarters at 0, 
7, 24 and 48 h post infusion. Control quarters acted as internal controls for each animal. 
There was a significant difference (P < 0.05) in lactoferrin mRNA levels between the control 
and infused quarters at 7 h post infusion (Table 1) with lactoferrin mRNA levels reduced in 
the infused quarter. At all other time points tested, lactoferrin mRNA levels did not 
significantly differ between the control and infused quarters (Table 1). Lactoferrin protein 
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levels were significantly increased (P < 0.05) in infused quarters compared to control quarters 
at 48 h post infusion (Table 2) 
 
Antibacterial activity 
To investigate the influence of a commercial preparation of bovine lactoferrin on the growth 
of the S. dysgalactiae culture DPC5345 in a laboratory setting a 24 h growth curve was 
performed. DPC5345 was cultured in complex media with various concentrations of 
lactoferrin. Results from the 24 h growth curves demonstrated that lactoferrin had a 
bacteriostatic effect on S. dysgalactiae DPC5345 (Figure 1). At 14 h  0.2 mg/ml lactoferrin 
had a significant effect on bacterial growth (P < 0.05) when compared to the control (no 
lactoferrin).  
 
Invasion assay and Confocal Imaging 
To examine if lactoferrin influenced the ability of S. dysgalactiae DPC5345 to invade 
epithelial cells, an invasion assay was performed using the HC-11 murine mammary 
epithelial cell line. HC-11 cell monolayers were incubated with ~1 x 107 CFU/ml of fresh 
bacterial culture and a range of physiologically relevant concentrations of lactoferrin from 
0.01-2.0 mg/ml (Schanbacher et al., 1993). After 4 h incubation lactoferrin reduced the 
number of live bacteria in the cell lysate in a dose dependent manner with significant 
reductions associated with 0.1, 1.0 and 2.0 mg/ml lactoferrin compared to the negative 
control. At 2 mg/ml of lactoferrin, more than a log fold reduction in the number of 
internalised bacteria (4.1 log10 CFU/ml) was observed compared to the negative control 
(5.52 log10 CFU/ml) and 0.01 mg/ml lactoferrin (5.34 log10 CFU/ml (Table 3). The 
adherence index value was calculated by dividing the number of bacterial CFUs in the cell 
lysate by the number of CFUs in the supernatant and therefore gives an indication of the 
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ability of the bacteria to adhere and internalise into HC-11 cells. In the absence of lactoferrin, 
the adherence index value was 37.72.  With each increasing lactoferrin concentration (0.01, 
0.1, 1.0 and 2.0 mg/ml) the adherence index value reduced (32.5, 20.67, 13.54 and 3.35 
respectively) in a dose dependent manner (Table 3), demonstrating decreased internalisation. 
This effect was visually confirmed by confocal microscopy (Figure 2) which showed that in 
the absence of lactoferrin viable S. dysgalactiae bacteria internalised into the mammary HC-
11 cells (Figures 2A and 2B respectively). When the Dylight 633 fluorescently labelled 
lactoferrin (~2 mg/ml) was added to the HC-11 cells, the labelled protein bound to the 
bacteria at HC-11 cell membrane boundaries (Figure 2C) and also to the bacteria that had 
internalised within the HC-11 cells (Figure 2D). These microscopic images indicate that S. 
dysgalactiae bacteria and the lactoferrin protein co-localise.  
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DISCUSSION 
A deliberate bovine intramammary challenge with S. dysgalactiae resulted in a significant 
increase (P < 0.05) in milk lactoferrin protein compared to controls. Follow up in vitro 
studies demonstrated that lactoferrin is a bacteriostatic agent that interferes with the ability of 
S. dysgalactiae to adhere and internalise into mammary epithelial cells. Co-localisation 
images suggest a direct interaction between lactoferrin and S. dysgalactiae cells 
demonstrating that this bacteria binds to the lactoferrin protein. The combined data indicates 
that a bovine immune response to S. dysgalactiae infection includes increased milk 
lactoferrin levels and this immune protein appears to limit mammary cell invasion of this 
pathogen by binding to the bacteria and reducing host cell adherence. 
 For some mastitis pathogens it has been shown that lactoferrin promotes the 
pathogenicity of the bacteria. Patel et al., (2009) demonstrated, in vitro, that lactoferrin 
served as a molecular bridge for Streptococcus uberis (S. uberis) species, promoting bacterial 
internalisation into mammary epithelial cells and potentially providing an opportunity for this 
pathogen to survive against host defence mechanisms. In contrast to this our study indicates 
that lactoferrin plays a role in preventing infection by S. dysgalactiae species by interfering 
with bacterial adhesion of the mammary epithelial cell. This has significance with regards to 
establishing intramammary infections by this pathogen, as adherence is an important stage in 
the pathogenesis of bovine mastitis (Calvinho et al., 1998).  
The main bacteriostatic effect of lactoferrin is thought to be due to its iron-
sequestering ability. When iron is depleted from the environment it limits the growth of 
pathogens (Lacasse et al., 2008). However, streptococcal species have a low iron requirement 
(Fang et al., 2000) and therefore alternative mechanisms must exist by which lactoferrin is 
bacteriostatic against streptococci. Park et al (2002a) demonstrated that, similar to S. uberis 
species, S. dysgalactiae express lactoferrin binding proteins (LFBPs).  The existence of these 
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proteins facilitates an interaction between lactoferrin and S. dysgalactiae cells (Park et al 
2002b) but the mechanism of the interaction and the physiological effect is unknown. 
Barboza et al. (2012) demonstrated that the glycan component of lactoferrin plays an 
essential role in pathogen recognition and inhibits bacterial binding to host epithelial cells. 
Other studies have confirmed that when lactoferrin binds with bacterial proteins it is capable 
of interfering with essential bacterial processes. Ochoa et al (2003) and Gomez et al (2003) 
have shown that lactoferrin can inhibit the function of type III secretory systems in the gram 
negative pathogens enteropathogenic E. coli and Shigella flexneri respectively. These 
secretory systems play a significant role in the adherence and invasion of these gram negative 
pathogens into mammalian cells. Lactoferrin was shown to inhibit pathogen adherence to 
host cells via a mechanism that involved proteolytic degradation of essential proteins required 
for bacterial contact and pore formation (Ochoa et al., 2003). Results from the current study 
demonstrate that lactoferrin is bacteriostatic against S. dysgalactiae species which could be 
due to the presence of these LFBPs. Further characterisation of these proteins within S. 
dysgalactiae is required and would offer more insight into the mechanism of interaction 
between this streptococcal species and lactoferrin. This would help further elucidate the role 
that lactoferrin plays in limiting mastitis infection caused by S. dysgalactiae and could 
potentially lead to alternative control strategies for mastitis caused by this pathogen. 
Although it could be argued that only one strain was examined in the present study, Park et al 
(2002b) demonstrated that there was no difference in the lactoferrin binding capacity of 
several S. dysgalactiae species investigated.  
Lactoferrin mRNA levels were reduced in the early period of invasion of 
S.dysgalactiae. Lactoferrin protein levels did not differ within this time period but later, at  
48 h post-infusion, there was a statistically significant increase (P<0.05) in the average milk 
lactoferrin levels from the infused quarters compared to the control quarters. Bovine milk 
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lactoferrin levels are reported in general to be between 20 - 200 mg/L (Rainard and Riollet, 
2006) but levels vary from one animal to another, vary in mammary quarters and as lactation 
progresses the mean lactoferrin concentration increases (Cheng et al., 2008).  In some cases 
of mastitis levels also increase (Kawai et al., 1999). Chaneton et al. (2008) reported that in 
subclinical bovine mastitis cases, when the individual contribution of each pathogen was 
investigated, S. dysgalactiae infections were not associated with a significant increase in milk 
lactoferrin levels. In clinical mastitis cases where there was a significant increase in milk 
lactoferrin, the causative bacteria was not known.  Whether the increase in milk lactoferrin 
levels observed in this study is biologically significant warrants further investigation.   
Mammary epithelial cells not only sense bacterial pathogens but also recruit neutrophils to 
the site of infection (Rainard and Riollet, 2006; Strandberg et al., 2005). This boosts the local 
concentration of lactoferrin protein as it is released from neutrophil secondary granules (Zhao 
and Lacasse, 2008). The increased levels of lactoferrin concentration at 48 h post infusion 
may therefore be as a result of neutrophil recruitment or delayed lactoferrin production from 
mammary epithelial cells or both.    
The results from this study further emphasise that the interaction between the milk 
protein lactoferrin and bacteria is species-specific.  Further studies are required to 
characterise this interaction and understand the host-pathogen response in S. dysgalactiae 
infections to pave the way for the development of bacterial targeted mastitis therapies and 
prophylactics. 
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Figure Legends 
Figure 1: Twenty-four hour growth curves of S. dysgalactiae in the presence of bovine 
lactoferrin. S. dysgalactiae DPC5345 was co-incubated with bovine lactoferrin protein at 
concentrations 0, 0.02, 0.2, 2.0, 5.0 and 10.0 mg/mL (denoted by ♦, ■, ▲, ○, × and ● 
respectively. Growth of DPC5345 was measured by turbidity (absorbance at 590 nm). S. 
dysgalactiae DPC5345 growth curves in the presence of each concentration of lactoferrin 
were compared to its growth in the absence of lactoferrin. From 8 h onwards there was a 
significant difference (P < 0.05), denoted as *, between growth of DPC5345 in the presence 
of  2 mg/mL lactoferrin compared to growth of DPC5345 alone.  
 
 
Figure 2: Confocal microscopic images of HC-11 mammary cells seeded at 1 x 106 cells and 
grown to confluency.  HC-11 cells were exposed to 1 x 107 CFU/mL S. dysgalactiae alone 
and with 2 mg/ml Dylight 633 fluorescently labelled lactoferrin.  All exposed cells were 
incubated for 2 h at 37 ◦C, 5 % CO2, the media was removed and the cells washed, then 
stained with Live/Dead Baclight viability stain to visualise cells. (A) viable S. dysgalactiae 
(stained bright green) adhering to the viable HC-11 cell surface  (B) following 2 h incubation, 
viable S. dysgalactiae (stained green) were seen internalised in viable HC-11 cells (identified 
with black arrows), (C) HC-11 cells (green stain) incubated with 2 mg/mL labelled lactoferrin 
(red stain) only. The lactoferrin crossed the cell membrane and collected in the cytoplasm of 
the cell, (D)  HC11 cells exposed to 1 x 107 CFU/mL S. dysgalactiae (viable bacteria are 
stained green) and 2 mg/mL lactoferrin (red stain).  
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Table 1. Lactoferrin transcript levels, per ng total RNA, in milk from S. dysgalactiae 
infused quarters compared to control quarters. Values are given as the exponential of 
transformed data + 95 % confidence intervals (95 % CI). (NS = Not Significant; P < 0.05 
indicates a significance difference at that time point; n = number of animals measured at each 
time point) 
 
Time (n) 
Control quarter S.dysgalactiae Infused quarter 
P Value 
Average 
lactoferrin 
mRNA Value 95 % CI 
Average 
lactoferrin 
mRNA Value 95 % CI 
0 h (n = 5) 1570 1,038 – 3,065 1883 1,324 – 4,464 NS 
7 h (n = 5) 5280 4,369 – 25,333 583 439 – 1,778 < 0.05 
24 h (n = 5) 1731 1,219 – 4,122 1336 940 – 3,169 NS 
48 h  (n = 5) 7572 5,008 – 14,789 2871 2,019 – 6,807 NS 
 
 
 
 
Table 2. Lactoferrin protein (µg/mL) in milk from S. dysgalactiae infused quarters compared 
to control quarters. Values are given as the average data of 5 animals + standard deviation. 
(SD = Standard Deviation; NS = Not Significant; P < 0.05 indicates significantly different at 
that time point; n = number of animals measured at each time point). 
 
Time (n) 
 Control quarter S. dysgalactiae infused quarter 
P Value Average Value SD Average Value SD 
0 h (n = 5) 199 64 189 64 NS 
7 h (n = 5) 168 64 177 64 NS 
24 h (n = 5) 215 64 259 64 NS 
48 h (n = 5) 230 64 301 64 < 0.05 
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Table 3. Effect of lactoferrin concentrations (mg/mL) on adherence and invasion of  
S. dysgalactiae DPC5345 (CFU/mL) into HC-11 mammary epithelial cells (1 x 105 
cells/well).  Adherence index calculated as (CFU in the cell lysates) / (CFU in the 
supernatant) X 10,000 (Fang et al., 2000).  
 Invasion Assay  
Lactoferrin 
(mg/ml) 
Live bacteria in 
supernatant 
(CFU/mL) 
Live bacteria in  
cell lysate 
(CFU/mL) 
Adherence 
Index 
0 8.80E + 07 (±8.68E+06) 3.32E + 05 (±4.93E+04) 37.72 
0.01 6.80E + 07 a (±5.68E+06) 2.21E + 05a (±3.20E+04) 32.5 
0.1 6.58E + 07 a (7.58E+06) 1.36E + 05b (±4.08E+04) 20.67 
1.0 6.94E + 07 a (7.32E+06) 9.40E + 04b (±3.45E+04) 13.54 
2.0 3.70E + 07 b (4.14E+06) 1.24E + 04b (±1.16E+03) 3.35 
 Values given represent mean of replicates (n = 8) (±SEM) of live bacterial recovered (CFU/ml) from HC-11 
cell supernatant or cell lysate in the invasion assay. Comparing data within columns a indicates lactoferrin 
concentration tested had no significant effect on bacterial cell count (CFU/mL) compared to control (no 
lactoferrin); b indicates lactoferrin concentration tested had significant (P < 0.05) effect on bacterial cell count 
(CFU/mL) compared to control (no lactoferrin)  
 
 
 
